The limited sample size also prevented a robust evaluation of significant associations between MCL-1 expression and documented prognostic factors, including age, liver enzyme levels (ALT and AST), subtypes, and tumor location [3, 39]. This evidence concerns the gene MCL1 and neoplasm.